News
The pathological complete response predicts a better prognosis in advanced rectal cancer
Studies review Referència de l’article
Researchers find a biomarker that predicts a good response to a new drug against breast cancer
Epigenetic inactivation of BRCA1 enhances the effect of PARP inhibitors in breast tumors Paper reference:
Manel Esteller, awarded by the International Union of Toxicology
IDIBELL’s researcher has been bestowed with the Deichmann Award
El Programa de teràpia cel·lular aproparà a la pràctica clínica els resultats de la recerca
The program’s objective is coordinating the efforts of twenty-four leading research groups working in the field of the stem cell translational research. Today, nineteen of these teams are clinical research groups (eighteen of them belong to IDIBAPS – Hospital Clinic de Barcelona and one to Bellvitge Biomedical Research Institute (IDIBELL). The five remaining centers provide …
